Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lipovitan D
- Development stage
- Unknown
- Lead developer
- Taisho Pharmaceutical
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Lipovitan D is a prominent energy drink and nutritional tonic developed and marketed by Taisho Pharmaceutical. Originally introduced in 1962, it is classified as a "designated quasi-drug" in Japan, a category for products with mild pharmacological actions. The formulation is a combination of 1,000 mg of taurine, 50 mg of anhydrous caffeine, and a complex of B vitamins including thiamine nitrate (B1), riboflavin sodium phosphate (B2), pyridoxine hydrochloride (B6), and nicotinamide, along with inositol. It is primarily indicated for the recovery from and prevention of physical fatigue, maintenance of physical strength and concentration, and as a nutritional supplement during illness, pregnancy, or lactation. The product functions by supporting the body's energy metabolism cycles and providing a central nervous system stimulant effect via caffeine.
- Brand names
- Lipovitan D
- Other names
- LipovitanLibogen
02
Targets
ADOR (Adenosine receptors)
Beyond the preview
Go deeper on Lipovitan D.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Lipovitan D.